Literature DB >> 308809

Immunological abnormalities in bronchiectasis with chronic bronchial suppuration.

A M Hilton, L Doyle.   

Abstract

Fifty-three patients with bronchiectasis (chronic bronchial suppuration) of unknown cause, in whom the chronic production of purulent sputum was the prominent clinical feature, were investigated for possible immunological abnormalities. They were compared with two control groups comprising 50 patients with chronic bronchitis and emphysema and 33 patients with bronchial asthma. Forty-two patients with bronchiectasis(79%) had at least one abnormality of immunoglobulin, usually elevation of IgA, IgG or IgM. Eight patients had all three immunoglobulin levels raised and this was related to severity of disease. Similar increases in immunoglobulin levels were observed in the control groups, but the frequency and severity of these changes were significantly greater in the bronchiectasis patients. Two patients had IgA deficiency. There was a very high prevalence of rheumatoid factor (52%) and an increased prevalence of antinuclear factor (10%) in the bronchiectasis patients compared with the control groups. The presence of these autoantibodies did not correlate closely with severity of disease. Ten patients with bronchiectasis (19%) had one or more autoimmune disorders, and the association of severe bronchiectasis, Hashimoto's thyroiditis and pernicious anaemia in one patient is described in detail. The immunoglobulin changes, high incidence of autoantibodies and association with autoimmune disorders raises the possibility that in some patients with bronchiectasis (chronic bronchial suppuration) of apparent unknown cause abnormal immune mechanisms may be important in causing or perpetuating the condition.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308809     DOI: 10.1016/0007-0971(78)90043-8

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  13 in total

1.  Prevalence of asthma, atopy, and bronchial hyperreactivity in bronchiectasis: a controlled study.

Authors:  J Pang; H S Chan; J Y Sung
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

Review 2.  Chronic suppurative lung disease with associated vasculitis.

Authors:  I N Bruce; J A McAteer; P V Gardiner; R J McFarland; J M Sloan; A L Bell
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

3.  Cutaneous vasculitis and immune complexes in severe bronchiectasis.

Authors:  A M Hilton; P S Hasleton; A Bradlow; B C Leahy; K M Cooper; M Moore
Journal:  Thorax       Date:  1984-03       Impact factor: 9.139

4.  Development of microscopic polyangiitis in patients with chronic airway disease.

Authors:  K Takahashi; S Hayashi; O Ushiyama; N Sueoka; M Fukuoka; K Nagasawa
Journal:  Lung       Date:  2005 Jul-Aug       Impact factor: 2.584

5.  IgG subclasses in the serum and sputum from patients with bronchiectasis.

Authors:  S L Hill; J L Mitchell; D Burnett; R A Stockley
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

6.  C1q binding activity in the sera of patients with chronic lung diseases.

Authors:  K M Cooper; M Moore; A M Hilton
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

7.  Systemic antibody deficiency in patients without serum immunoglobulin deficiency or with selective IgA deficiency.

Authors:  M A French; G Harrison
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

8.  Atopy, immunological changes, and respiratory function in bronchiectasis.

Authors:  M B Murphy; D J Reen; M X Fitzgerald
Journal:  Thorax       Date:  1984-03       Impact factor: 9.139

9.  Bronchiectasis and rheumatoid arthritis: a clinical study.

Authors:  M J McMahon; D R Swinson; S Shettar; R Wolstenholme; C Chattopadhyay; P Smith; P Johns; N H Crosby
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

10.  Serum IgG subclasses in chronic and recurrent respiratory infections.

Authors:  P J Stanley; G Corbo; P J Cole
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.